BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böttger F, Schaaij-visser TB, de Reus I, Piersma SR, Pham TV, Nagel R, Brakenhoff RH, Thunnissen E, Smit EF, Jimenez CR. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction. Journal of Proteomics 2019;196:106-19. [DOI: 10.1016/j.jprot.2019.01.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kastora SL, Kounidas G, Speirs V, Masannat YA. Integrative, In Silico and Comparative Analysis of Breast Cancer Secretome Highlights Invasive-Ductal-Carcinoma-Grade Progression Biomarkers. Cancers 2022;14:3854. [DOI: 10.3390/cancers14163854] [Reference Citation Analysis]
2 D'Amato M, Iadarola P, Viglio S. Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today? Int J Mol Sci 2022;23:5692. [PMID: 35628501 DOI: 10.3390/ijms23105692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mani S, Parthiban L. Predictive Analytics Framework for Lung Cancer with Data Mining Methods. Lecture Notes in Networks and Systems 2022. [DOI: 10.1007/978-3-030-84760-9_67] [Reference Citation Analysis]
4 Luo J, Hu Q, Gou M, Liu X, Qin Y, Zhu J, Cai C, Tian T, Tu Z, Du Y, Deng H. Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer. Front Oncol 2021;11:680402. [PMID: 34660263 DOI: 10.3389/fonc.2021.680402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Xie Q, Wang D, Luo X, Li Z, Hu A, Yang H, Tang J, Gao P, Sun T, Kong L. Proteome profiling of formalin-fixed, paraffin-embedded lung adenocarcinoma tissues using a tandem mass tag-based quantitative proteomics approach. Oncol Lett 2021;22:706. [PMID: 34457061 DOI: 10.3892/ol.2021.12967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Song D, Guo M, Wu K, Hao J, Nie Y, Fan D. Silencing of ER-resident oxidoreductase PDIA3 inhibits malignant biological behaviors of multidrug-resistant gastric cancer. Acta Biochim Biophys Sin (Shanghai) 2021;53:1216-26. [PMID: 34363072 DOI: 10.1093/abbs/gmab101] [Reference Citation Analysis]
7 Shnaider PV, Ivanova OM, Malyants IK, Anufrieva KS, Semenov IA, Pavlyukov MS, Lagarkova MA, Govorun VM, Shender VO. New Insights into Therapy-Induced Progression of Cancer. Int J Mol Sci 2020;21:E7872. [PMID: 33114182 DOI: 10.3390/ijms21217872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xu C, Zhang J, Liu J, Li Z, Liu Z, Luo Y, Xu Q, Wang M, Zhang G, Wang F, Chen H. Proteomic analysis reveals the protective effects of emodin on severe acute pancreatitis induced lung injury by inhibiting neutrophil proteases activity. J Proteomics 2020;220:103760. [PMID: 32244009 DOI: 10.1016/j.jprot.2020.103760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Cury SS, Lapa RML, de Mello JBH, Marchi FA, Domingues MAC, Pinto CAL, Carvalho RF, de Carvalho GB, Kowalski LP, Rogatto SR. Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma. Oral Oncol 2020;103:104592. [PMID: 32087405 DOI: 10.1016/j.oraloncology.2020.104592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
10 Nishikawa T, Fujii T, Tatsumi S, Sugimoto A, Sekita-Hatakeyama Y, Shimada K, Yamazaki M, Hatakeyama K, Ohbayashi C. Molecular Analysis of Liquid-Based Cytological Specimen Using Virtually Positive Sputum with Adenocarcinoma Cells. Diagnostics (Basel) 2020;10:E84. [PMID: 32033355 DOI: 10.3390/diagnostics10020084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Erozenci LA, Böttger F, Bijnsdorp IV, Jimenez CR. Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome. FEBS Lett 2019;593:1580-97. [DOI: 10.1002/1873-3468.13487] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]